Rollag, Halvor <br/><br/>
Treatment of cytomegalovirus disease in solid organ transplant recipients:  markers of inflammation as predictors of outcome.  [electronic resource] 

 -  Transplantation  Nov 2012 
 - 1060-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e31826c39de  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Chemokine CXCL16<br/>Chemokines, CXC--blood<br/>Cytomegalovirus Infections--blood<br/>Female<br/>Follow-Up Studies<br/>Ganciclovir--analogs & derivatives<br/>Humans<br/>Inflammation--blood<br/>Kidney Transplantation<br/>Liver Transplantation<br/>Male<br/>Middle Aged<br/>Outcome Assessment, Health Care<br/>Postoperative Complications--blood<br/>Predictive Value of Tests<br/>Receptors, Scavenger--blood<br/>Serum Amyloid P-Component--metabolism<br/>Transplantation<br/>Treatment Outcome<br/>Valganciclovir<br/>von Willebrand Factor--metabolism